Download PDF
Aktuelle Dermatologie 2012; 38(6): 217-228
DOI: 10.1055/s-0032-1306695
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Rosazea

RosaceaI.  Pfeffer1 , M.  Schaller1
  • 1Universitäts-Hautklinik, Universitätsklinikum Tübingen
Further Information

Publication History

Publication Date:
25 May 2012 (online)

Also available at
   Permissions and Reprints

Lernziele

Kenntnisse über:

Stadieneinteilung

Sonderformen

Triggerfaktoren

Pathogenese

Prophylaxe und Therapiemöglichkeiten

Literatur

  • 1 Berg M, Lidén S. An epidemiological study of rosacea.  Acta Derm Venereol. 1989;  69 419-423
    Google Scholar
  • 2 Yamasaki K, Gallo R L. The molecular pathology of rosacea.  J Dermatol Sci. 2009;  55 77-81
    Google Scholar
  • 3 National Rosacea Society .Rosacea Review.  Im Internet: http://www.rosacea.org/rr/2008/spring/article_3.php Stand: 18.07.2008
    Google Scholar
  • 4 Gauwerky K, Klövekorn W, Korting H C et al. Rosacea.  J Dtsch Dermatol Ges. 2009;  7 996-1003
    Google Scholar
  • 5 Crawford G H, Pelle M T, James W D. Rosacea: I. Etiology, pathogenesis, and subtype classification.  J Am Acad Dermatol. 2004;  51 327-341
    Google Scholar
  • 6 Lehmann P. Rosacea. Clinical features, pathogenesis and therapy.  Hautarzt. 2005;  56 871-885
    Google Scholar
  • 7 Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities.  Facial Plast Surg. 1998;  14 241-253
    Google Scholar
  • 8 Ezra N, Greco J F, Haley J C et al. Gnatophyma and otophyma.  J Cutan Med Surg. 2009;  13 266-272
    Google Scholar
  • 9 Aloi F, Tomasini C, Soro E et al. The clinicopathologic spectrum of rhinophyma.  J Am Acad Dermatol. 2000;  42 468-472
    Google Scholar
  • 10 Burton J L, Pye R J, Meyrick G et al. The sebum excretion rate in rosacea.  Br J Dermatol. 1975;  92 541-543
    Google Scholar
  • 11 Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal.  Am J Clin Dermatol. 2002;  3 273-282
    Google Scholar
  • 12 Forton F, Germaux M A, Brasseur T et al. Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice.  J Am Acad Dermatol. 2005;  52 74-87
    Google Scholar
  • 13 Zhao Y E, Wu L P, Peng Y et al. Retrospective analysis of the association between Demodex infestation and rosacea.  Arch Dermatol. 2010;  146 896-902
    Google Scholar
  • 14 Yamasaki K, di Nardo A, Bardan A et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.  Nat Med. 2007;  13 975-980
    Google Scholar
  • 15 Sibenge S, Gawkrodger D J. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum.  J Am Acad Dermatol. 1992;  26 590-593
    Google Scholar
  • 16 Gomaa A H, Yaar M, Eyada M M et al. Lymphangiogenesis and angiogenesis in non-phymatous rosacea.  J Cutan Pathol. 2007;  34 748-753
    Google Scholar
  • 17 Brauchle M, Funk J O, Kind P et al. Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes.  J Biol Chem. 1996;  271 21 793-21 797
    Google Scholar
  • 18 Bakar O, Demirçay Z, Yuksel M et al. The effect of azithromycin on reactive oxygen species in rosacea.  Clin Exp Dermatol. 2007;  32 197-200
    Google Scholar
  • 19 Akamatsu H, Oguchi M, Nishijima S et al. The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne.  Arch Dermatol Res. 1990;  282 449-454
    Google Scholar
  • 20 Yoshioka A, Miyachi Y, Imamura S et al. Anti-oxidant effects of retinoids on inflammatory skin diseases.  Arch Dermatol Res. 1986;  278 177-183
    Google Scholar
  • 21 Baudouin C. A new approach for better comprehension of diseases of the ocular surface.  J Fr Ophtalmol. 2007;  30 239-246
    Google Scholar
  • 22 Akpek E K, Merchant A, Pinar V et al. Ocular rosacea: patient characteristics and follow-up.  Ophthalmology. 1997;  104 1863-1867
    Google Scholar
  • 23 Quarterman M J, Johnson D W, Abele D C et al. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline.  Arch Dermatol. 1997;  133 49-54
    Google Scholar
  • 24 Plewig G. Akne und Rosazea.. In: Braun-Falco O, Plewig G, Wolff H, et al., Hrsg Dermatologie und Venerologie.. 5. Aufl. Heidelberg, Berlin: Springer; 2005
    Google Scholar
  • 25 Plewig G, Jansen T, Kligman A M. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea?.  Arch Dermatol. 1992;  128 1611-1617
    Google Scholar
  • 26 Jansen T, Plewig G, Kligman A M. Diagnosis and treatment of rosacea fulminans.  Dermatology. 1994;  188 251-254
    Google Scholar
  • 27 Culp B, Scheinfeld N. Rosacea: A Review.  P T. 2009;  34 38-45
    Google Scholar
  • 28 Helm K F, Menz J, Gibson L E et al. A clinical and histopathologic study of granulomatous rosacea.  J Am Acad Dermatol. 1991;  25 1038-1043
    Google Scholar
  • 29 Meykadeh N, Meiss F, Marsch W C et al. Steroid-aggravated rosacea: successful therapy with pimecrolimus.  Hautarzt. 2007;  58 338-342
    Google Scholar
  • 30 Rathi S K, Kumrah L. Topical corticosteroid-induced rosacea-like dermatitis: a clinical study of 110 cases.  Indian J Dermatol Venereol Leprol. 2011;  77 42-46
    Google Scholar
  • 31 Lamparter J, Kottler U, Cursiefen C et al. Morbus Morbihan: A rare cause of edematous swelling of the eyelids.  Ophthalmologe. 2010;  107 553-557
    Google Scholar
  • 32 Nagasaka T, Koyama T, Matsumura K et al. Persistent lymphoedema in Morbihan disease: formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis.  Clin Exp Dermatol. 2008;  33 764-767
    Google Scholar
  • 33 Jansen T, Regele D, Schirren C G et al. Persistent erythema and edema of the face associated with rosacea and lymph vessel dysplasia.  Hautarzt. 1998;  49 932-935
    Google Scholar
  • 34 Drolet B, Paller A S. Childhood rosacea.  Pediatr Dermatol. 1992;  9 22-26
    Google Scholar
  • 35 Chamaillard M, Mortemousque B, Boralevi F et al. Cutaneous and ocular signs of childhood rosacea.  Arch Dermatol. 2008;  144 167-171
    Google Scholar
  • 36 Hong E, Fischer G. Childhood ocular rosacea: considerations for diagnosis and treatment.  Australas J Dermatol. 2009;  50 272-275
    Google Scholar
  • 37 Bostanci O, Borelli C, Schaller M. Treatment of extrafacial rosacea with low-dose isotretinoin.  Acta Derm Venereol. 2010;  90 409-410
    Google Scholar
  • 38 Pereira T M, Vieira A P, Basto A S. Rosacea with extensive extrafacial lesions.  Int J Dermatol. 2008;  47 52-55
    Google Scholar
  • 39 Yentzer B A, Fleischer Jr A B. Changes in rosacea comorbidities and treatment utilization over time.  J Drugs Dermatol. 2010;  9 1402-1406
    Google Scholar
  • 40 Gollnick H, Blume-Peytavi U, Szabó E L et al. Systemic isotretinoin in the treatment of rosacea – doxycycline- and placebo-controlled, randomized clinical study.  J Dtsch Dermatol Ges. 2010;  8 505-515
    Google Scholar
  • 41 van Zuuren E J, Kramer S, Carter B et al. Interventions for rosacea.  Cochrane Database Syst Rev. 2011;  3 CD003262
    Google Scholar
  • 42 Sobottka A, Lehmann P. Rosacea 2009: new advances in pathophysiology, clinical staging and therapeutic strategies.  Hautarzt. 2009;  60 999-1009
    Google Scholar
  • 43 Madsen J T, Thormann J, Kerre S et al. Allergic contact dermatitis to topical metronidazole – 3 cases.  Contact Dermatitis. 2007;  56 364-366
    Google Scholar
  • 44 Mastrofrancesco A, Ottaviani M, Aspite N et al. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation.  Exp Dermatol. 2010;  19 813-820
    Google Scholar
  • 45 Elewski B E, Fleischer Jr A B, Pariser D M. A comparison of 15 % azelaic acid gel and 0.75 % metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.  Arch Dermatol. 2003;  139 1444-1450
    Google Scholar
  • 46 Frampton J E, Wagstaff A J. Azelaic acid 15 % gel: in the treatment of papulopustular rosacea.  Am J Clin Dermatol. 2004;  5 57-64
    Google Scholar
  • 47 Liu R H, Smith M K, Basta S A et al. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials.  Arch Dermatol. 2006;  142 1047-1052
    Google Scholar
  • 48 Torok H M, Webster G, Dunlap F E et al. Combination sodium sulfacetamide 10 % and sulfur 5 % cream with sunscreens versus metronidazole 0.75 % cream for rosacea.  Cutis. 2005;  75 357-363
    Google Scholar
  • 49 Koçak M, Yağli S, Vahapoğlu G et al. Permethrin 5 % cream versus metronidazole 0.75 % gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.  Dermatology. 2002;  205 265-270
    Google Scholar
  • 50 Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report.  J Am Acad Dermatol. 2001;  44 995-998
    Google Scholar
  • 51 Bhat Y J, Manzoor S, Qayoom S. Steroid-induced rosacea: a clinical study of 200 patients.  Indian J Dermatol. 2011;  56 30-32
    Google Scholar
  • 52 Breneman D, Savin R, VandePol C et al. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.  Int J Dermatol. 2004;  43 381-387
    Google Scholar
  • 53 Korting H C, Schöllmann C. Current topical and systemic approaches to treatment of rosacea.  J Eur Acad Dermatol Venereol. 2009;  23 876-882
    Google Scholar
  • 54 Altinyazar H C, Koca R, Tekin N S et al. Adapalene vs. metronidazole gel for the treatment of rosacea.  Int J Dermatol. 2005;  44 252-255
    Google Scholar
  • 55 Goldgar C, Keahey D J, Houchins J. Treatment options for acne rosacea.  Am Fam Physician. 2009;  80 461-468
    Google Scholar
  • 56 Monk E, Shalita A, Siegel D. Clinical applications of non-antimicrobial tetracyclines in dermatology.  Pharmacol Res. 2011;  63 130-145
    Google Scholar
  • 57 Alvarenga L S, Mannis M J. Ocular rosacea.  Ocul Surf. 2005;  3 41-58
    Google Scholar
  • 58 Korting H C, Schöllmann C. Tetracycline actions relevant to rosacea treatment.  Skin Pharmacol Physiol. 2009;  22 287-294
    Google Scholar
  • 59 Iovieno A, Lambiase A, Micera A et al. In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis.  Eur J Ophthalmol. 2009;  19 708-716
    Google Scholar
  • 60 Baldwin H E. Systemic therapy for rosacea.  Skin Therapy Lett. 2007;  12 1-5, 9
    Google Scholar
  • 61 Pfeffer I, Borelli C, Zierhut M, Schaller M. Treatment of ocular rosacea with 40 mg doxycycline in a slow release form.  J Dtsch Dermatol Ges. 2011;  9 904-907
    Google Scholar
  • 62 Del R osso. Anti-inflamatory dose doxycycline in the treatment of rosacea.  J Drugs Dermatol. 2009;  8 664-668
    Google Scholar
  • 63 Akhyani M, Ehsani A H, Ghiasi M et al. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial.  Int J Dermatol. 2008;  47 284-288
    Google Scholar
  • 64 Guilhou J J, Guilhou E, Malbos S et al. [Metronidazole therapy in rosacea (author's transl)].  Ann Dermatol Venereol. 1979;  106 127-129
    Google Scholar
  • 65 Saihan E M, Burton J L. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea.  Br J Dermatol. 1980;  102 443-445
    Google Scholar
  • 66 Nikolowski J, Plewig G. Oral treatment of rosacea with 13-cis-retinoic acid.  Hautarzt. 1981;  32 575-584
    Google Scholar
  • 67 Jansen T, Plewig G. Rosacea: classification and treatment.  J R Soc Med. 1997;  90 144-150
    Google Scholar
  • 68 Shanler S D, Ondo A L. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline.  Arch Dermatol. 2007;  143 1369-1371
    Google Scholar
  • 69 Kim J H, Oh Y S, Ji J H et al. Rosacea (erythematotelangiectatic type) effectively improved by topical xylometazoline.  J Dermatol. 2011;  38 510-513
    Google Scholar
  • 70 Rørdam O M, Guldbakke K. Rhinophyma: big problem, simple solution.  Acta Derm Venereol. 2011;  91 188-189
    Google Scholar
  • 71 Moreira A, Leite I, Guedes R et al. Surgical treatment of rhinophyma using carbon dioxide (CO2) laser and pulsed dye laser (PDL).  J Cosmet Laser Ther. 2010;  12 73-76
    Google Scholar
  • 72 Kempiak S J, Lee P W, Pelle M T. Rhinophyma treated with cryosurgery.  Dermatol Surg. 2009;  35 543-545
    Google Scholar

Prof. Dr. med. Martin Schaller

Universitäts-Hautklinik

Liebermeisterstr. 25
72076 Tübingen

Email: Martin.Schaller@med.uni-tuebingen.de

      >